AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimbeat MV 2mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Brivan Biotech Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glimbeat MV 2mg/500mg/0.2mg Tablet

Diabexe Trio 2mg/500mg/0.2mg tablets are antidiabetic agents, a combination medication for adult type 2 diabetes. This treatment helps manage blood glucose. Diabexe Trio should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar; discontinuation without medical advice risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as recommended by your doctor; lifestyle significantly influences diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn its symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures (fast-acting glucose sources). Avoid alcohol, as it increases hypoglycemia risk. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver disease. Inform your doctor of any history of heart disease before commencing treatment; it may be unsuitable. Pregnant or breastfeeding individuals should seek medical consultation prior to use. Regular blood glucose monitoring and blood tests (cell counts, liver function) may be recommended by your physician.

Uses of Glimbeat MV 2mg/500mg/0.2mg Tablet

Managing Type 2 diabetes

Major Benefits of Glimbeat MV 2mg/500mg/0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimbeat MV 2mg/500mg/0.2mg Tablet on an empty stomach.

Common Side effects of Glimbeat MV 2mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimbeat MV 2mg/500mg/0.2mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimbeat MV 2mg/500mg/0.2mg Tablet whole; do not crush, chew, or divide it. Administer this medication on an empty stomach.

How Glimbeat MV 2mg/500mg/0.2mg Tablet works:

Each Glimbeat MV 2mg/500mg/0.2mg tablet contains a triple-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimbeat MV 2mg/500mg/0.2mg Tablet with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimbeat MV 2mg/500mg/0.2mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers before prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Glimbeat MV 2mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

The use of Glimbeat MV 2mg/500mg/0.2mg tablets is likely unsafe for individuals with kidney impairment and should be avoided. Patients with severe kidney disease should not take this medication. Medical advice is recommended.

LiverLiverCAUTION

Patients with liver impairment should use Glimbeat MV 2mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, a low initial dose is typically recommended; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimbeat MV 2mg/500mg/0.2mg Tablet :

Should you forget to take your Glimbeat MV 2mg/500mg/0.2mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimbeat MV 2mg/500mg/0.2mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimbeat MV 2mg/500mg/0.2mg Tablet

Glimbeat MV 2mg/500mg/0.2mg tablets contain glimepiride, metformin, and voglibose. This triple-drug formulation manages type 2 diabetes mellitus in adults, enhancing glycemic control when combined with a healthy diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion, reducing blood glucose. Metformin decreases hepatic glucose production and improves insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal blood sugar. This medication is unsuitable for type 1 diabetes.
Taking Glimbeat MV 2mg/500mg/0.2mg Tablets may cause common adverse reactions such as low blood glucose, queasiness, loose stools, taste disturbances, gas, abdominal discomfort, cephalalgia, dermatitis, and upper respiratory infections.
Patients with hypersensitivity to any Glimbeat MV 2mg/500mg/0.2mg Tablet constituent or inactive ingredient should not take this medication. Furthermore, its administration is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel conditions, colonic ulcers, and underlying metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol while taking Glimbeat MV 2mg/500mg/0.2mg Tablets is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimbeat MV 2mg/500mg/0.2mg Tablets can induce hypoglycemia, characterized by nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremors. This risk increases with skipped or delayed meals, alcohol consumption, strenuous activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is recommended.
Retain this medication within its original, sealed packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Glimbeat MV 2mg/500mg/0.2...
98
MRP 120
18% off